ReproCELL Incorporated (TYO:4978)
127.00
+4.00 (3.25%)
Jun 3, 2026, 3:30 PM JST
ReproCELL Employees
ReproCELL had 99 employees as of March 31, 2025. The number of employees increased by 3 or 3.13% compared to the previous year.
Employees
99
Change (1Y)
3
Growth (1Y)
3.13%
Revenue / Employee
22.56M JPY
Profits / Employee
-5.97M JPY
Market Cap
11.69B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 31, 2025 | 99 | 3 | 3.13% |
| Mar 31, 2024 | 96 | 4 | 4.35% |
| Mar 31, 2023 | 92 | -6 | -6.12% |
| Mar 31, 2022 | 98 | -8 | -7.55% |
| Mar 31, 2021 | 106 | -7 | -6.19% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| RaQualia Pharma | 85 |
| Carna Biosciences | 61 |
| Immuno-Biological Laboratories | 58 |
| OncoTherapy Science | 47 |
| StemRIM | 45 |
| Stella Pharma | 43 |
| Nano Holdings | 20 |
| K Pharma,Inc. | 20 |
ReproCELL News
- 3 months ago - ReproCELL Quarterly report: Q3 2026 - Filings
- 7 months ago - ReproCELL Quarterly report: Q2 2026 - Filings
- 10 months ago - ReproCELL Quarterly report: Q1 2026 - Filings